EP2819516
USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.7.2012EP published:
25.12.2019EP application number:
12820058.1
EPO information:
European Patent Register
Max expiry date:
26.7.2032
Title:
USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
Timeline
Today
27.7.2012EP application
25.12.2019EP Publication
Owner
Name:
Otsuka America Pharmaceutical, Inc.Address:
2440 Research Boulevard, Rockville, MD 20850, US
Inventor
Name:
MCKINNEY, Anthony AlexanderAddress:
Newton Center, MA 02459, US
Name:
BYMASTER, FrankAddress:
Brownsburg, IN 46112, US
Priority
Number:
201161574231 PDate:
30.7.2011Country:
US
Number:
201113334066Date:
22.12.2011Country:
US
Number:
201213528940Date:
21.6.2012Country:
US
Classification
Categories:
A61K 9/00, A61P 25/00, A61K 31/403